Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.
| Image |  |
|---|---|
| Description | scientific article published on 23 December 2014 |
| Author/s |
author: Thomas Gruenberger |
| Publication date | December 23, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |